Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.6620
-0.0180 (-2.65%)
Oct 2, 2026, 5:35 PM CET
Theraclion Market Cap
Theraclion has a market cap or net worth of €48.4 million as of October 2, 2026. Its market cap has increased by 39.20% in one year.
Market Cap
48.40M
Enterprise Value
56.25M
Revenue
480.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.66
ChartMarket Cap Chart
Since April 25, 2014, Theraclion's market cap has increased from 37.53M to 48.40M, an increase of 28.95%. That is a compound annual growth rate of 2.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 48.40M | 71.11% |
| Dec 31, 2025 | 28.28M | 85.64% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 340.06M |
| Eurobio Scientific Société anonyme | 252.71M |
| Median Technologies | 137.58M |
| Guerbet | 84.65M |
| Novacyt | 34.22M |
| Mauna Kea Technologies | 27.00M |
| Diagnostic Medical Systems | 23.48M |
| Implanet | 23.33M |